# OnCo record alexander-eggermont (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/alexander-eggermont/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "alexander-eggermont" ;
  schema:name "Alexander Eggermont"@en ;
  schema:description "Surgical oncologist who led the EORTC adjuvant ipilimumab and pembrolizumab trials in melanoma."@en ;
  schema:url <https://onco.cc/people/alexander-eggermont/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Eggermont%20AM%5BAuthor%5D%20adjuvant%20melanoma> ;
  schema:jobTitle "Chief Scientific Officer, Princess Máxima Center; Professor, Utrecht; former EORTC President" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:companies <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  schema:affiliation <https://onco.cc/companies/curie-nki-eortc/> .
